Nanomedicine Market Analysis With Key Players, Applications, Trends And Forecasts To 2026 – The Scarlet

DataIntelo report titled Global Nanomedicine Market provides detailed information and overview about the key influential factors required to make well informed business decision. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Our data has been culled out by our team of experts who have curated the report, considering market-relevant information. This report provides latest insights about the markets drivers, restraints, opportunities, and trends. It also discusses the growth and trends of various segments and the market in various regions.

Request Free Sample Report of Nanomedicine Market Report @ https://dataintelo.com/request-sample/?reportId=81345

Nanomedicine Market Report Includes:

For More Information on This Report Visit @ https://dataintelo.com/enquiry-before-buying/?reportId=81345

By Product Types:Quantum dotsNanoparticlesNanoshellsNanotubesNanodevices

The report is further broken down into various segments such as product types, applications, and regions.

By Applications:Segmentation encompasses oncologyInfectious diseasesCardiologyOrthopedicsOthers

Our analysts drafted the report by gathering information through primary (through surveys and interviews) and secondary (included industry body databases, reputable paid sources, and trade journals) methods of data collection. The report encompasses an exhaustive qualitative and quantitative evaluation.

The study includes growth trends, micro- and macro-economic indicators, and regulations and governmental policies.

By Regions:Asia Pacific (China, Japan, India, and Rest of Asia Pacific)Europe (Germany, the UK, France, and Rest of Europe)North America (the US, Mexico, and Canada)Latin America (Brazil and Rest of Latin America)Middle East & Africa (GCC Countries and Rest of Middle East & Africa)

The Nanomedicine Market Report Covers the Following Companies:CombimatrixAblynxAbraxis BioscienceCelgeneMallinckrodtArrowhead ResearchGE HealthcareMerckPfizerNanosphereEpeius BiotechnologiesCytimmune SciencesNanospectra Biosciences

The subject matter experts analyzed various companies to understand the products and/services relevant to the market. The report includes information such as gross revenue, production and consumption, average product price, and market shares of key players. Other factors such as competitive analysis and trends, mergers & acquisitions, and expansion strategies have been included in the report. This will enable the existing competitors and new entrants understand the competitive scenario to plan future strategies.

To Purchase This Report: https://dataintelo.com/checkout/?reportId=81345

The Report Provides:

The Nanomedicine Market Report Addresses the Following Queries:

For Best Discount on Purchasing this Report Visit https://dataintelo.com/ask-for-discount/?reportId=81345

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario,CA 91764, United States.Phone No: USA: +1 909 545 6473 | IND: +91-7000061386Email: [emailprotected]Website: https://dataintelo.com

Here is the original post:
Nanomedicine Market Analysis With Key Players, Applications, Trends And Forecasts To 2026 - The Scarlet

Revenue Growth of the Nanomedicine Market to be Influenced by Growing End-use Adoption – News Cast Report

AMR has recently added a new study titled Nanomedicine in theirs extensive and huge report catalog. This market intelligence research encapsulates vital details about the market flow as well as future status during the mentioned forecast period of 2025.

The Nanomedicine market size is predicted to witness enormous growth projections during 2019 2025. The notable factors that are expected to contribute to the growth of the Nanomedicine market during the forecast period.

With the slowdown in world economic growth, the Nanomedicine industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Nanomedicine market size to maintain the average annual growth rate of 7 from (2014 Market size XXXX) million $ in 2014 to (2019 Market size XXXX) million $ in 2019, our analysts believe that in the next few years, Nanomedicine market size will be further expanded, we expect that by 2024, The market size of the Nanomedicine will reach (2024 Market size XXXX) million $.

This 122-page market study report Nanomedicine is based on comprehensive research of the entire Nanomedicine.

Find out more about of the Nanomedicine market report at: https://www.amplemarketreports.com/report/global-nanomedicine-market-772150.html

This report offers up-to-date multiple market data on the tangible market situation and future outlook for the Nanomedicine.

This market report renders historical market data for 2013 2018, and forecasts from 2019 till 2025.

The study also targets essential aspects such as the latest trends, market drivers, challenges, and opportunities associated with the growth of producers in the global market for Nanomedicine.

This Report covers the manufacturers data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Principal Manufacturers Analysis on the Nanomedicine market included in this report:

The report also provides extensive profiles of the principal players across the globe in the Nanomedicine market as follows,

GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories

With important details on companies Portfolio, sales, strategies, and the latest developments with their decisions are likely to affect the market share during the forecast period. Along with these market insights, the study presents the readers important insights into the tactics performed by principal companies to remain in the top/lead of this competing market.

Get sample copy of this Report with more info on Key Players, Application, Type and Regions in your email box https://www.amplemarketreports.com/sample-request/global-nanomedicine-market-772150.html

Application Analysis on the Nanomedicine market:

The report encloses a deep study on the Application of the Nanomedicine market with size in terms of both value, volume, sales and more.

The report presents precise insight on Application into current and future evolutions of the Nanomedicine market.

Gross Margin, Sales, Market share, Growth, and much more aspects.

Application of the Nanomedicine divided by considering number of parameters along with end user usage and importance.

Regional Segment Analysis on the Nanomedicine market:

Extensive analysis has been prepared on distribution/supply, revenue/pricing, and demand with the effectiveness of the Nanomedicine.

Furthermore, It also provides a deep and thorough evaluation of the distribution channel and technique of the distribution.

The report also details the newest information about the Nanomedicine production, supply, and allocation by major corporations around the globe by focusing below the number of regions as,

North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy), Other Country (Middle East, Africa, GCC)

The Report Helps Answer the Following Questions:

Inquire more on Discounts or if any questions before the purchase of this report https://www.amplemarketreports.com/enquiry-before-buy/global-nanomedicine-market-772150.html

With the given market data, Research on Global Markets offers customizations according to specific needs.

AMR is a leading market research player that offers Professional market research reports and custom research across multi geographies and industry verticals.

AMR delivers an extensive array of cutting-edge analysis solutions that help organizations, corporations, institutions, and individuals in building more solid decisions of the business to business needs.

About Us

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to delivery reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Call: +1 (530) 868 6979

Email: sales@amplemarketreports.com

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

https://www.amplemarketreports.com

I am Mel Villarreal and Im passionate about business and finance news with over 4 years in the industry starting as a writer working my way up into senior positions.

Follow this link:
Revenue Growth of the Nanomedicine Market to be Influenced by Growing End-use Adoption - News Cast Report

Nanomedicine & Nanodrugs ZPH | Nanomedicinezph.com

Transferring this new technology in three branches:

Maturing the project from 2012 (8 years), in the right place and at the right time our nanoformulations started to navigate the medical evolution landscape in three challenge areas of (1) ZPH antibiotics innovation, (2) ZPH anti-cancer drugs, (3) and uncovering opportunities of a new ZPH nano-formulation against HIV/infectious diseases.

For each of these directions, the synthesis design was modified smartly (the key of success!). This remarkably refers to the obedience of our nanoformulation for an on-demand modification, and its very powerful medical potentials per se. Then, what we create is truly a multi-functional nanoplatform!

Nanomedicine & Nanodrugs ZPH can use the knowledge obtained in the development of antibiotics, anti-cancers (till now against 8 cancer cell lines) and anti-HIVs for drug development in other areas of diseases. Since there should be still hidden potentials for such a powerful nano-formulation design for more big successes, as well, that should be bravely tested. For example; brain cancer, pancreas cancer, etc., which have shown only small gains in survival with current drugs.

This nano-formulation is like this expression: Wie ein Held zum Siegen! (Symphony No.9, Op.125)

Continued here:
Nanomedicine & Nanodrugs ZPH | Nanomedicinezph.com

Nanotechnology In Medical Applications Market To Eyewitness Massive Growth Trends Market Research 2017 to 2022 – Scientect

Theglobal nanomedical marketwas valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017-2022, and should reach $293.1 billion by 2022 from $151.9 billion in 2017.

Request For Report[emailprotected]https://www.trendsmarketresearch.com/report/sample/12261

Report Scope:

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-inflammatories.

Report Includes:

An overview of the global markets for nanotechnology used in medical applications Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022 A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine Analysis of the markets dynamics, specifically growth drivers, inhibitors, and opportunities Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market

Get Complete TOC with Tables and [emailprotected]https://www.trendsmarketresearch.com/report/discount/12261

Summary

Nano-enabled medical products began appearing on the market over a decade ago, and some have become best-sellers in their therapeutic categories. The principal areas in which nanomedical products have made an impact are cancer, CNS diseases, cardiovascular disease and infection control. The Summary Table gives estimates of the historical and current markets for these nanomedicine areas with a forecast through 2022.

The U.S. market is by far the largest in the global nanomedicine market and is set to continue to dominate the world marketplace; however, other national markets are expected to increase their shares over the next five years.

Reasons for Doing the Study

Nanomedicine is already an established market. Unlike some other potential applications of nanotechnology, which are still largely experimental, nanomedicine has already produced some significant products in which the nano dimension has made a significant contribution to product effectiveness. Now that aspects of the nanomedicine market are established, it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future.

<<< Get COVID-19 Report Analysis >>>https://www.trendsmarketresearch.com/report/covid-19-analysis/12261

View post:
Nanotechnology In Medical Applications Market To Eyewitness Massive Growth Trends Market Research 2017 to 2022 - Scientect

Healthcare Nanotechnology Market 2020 : Industry Outlook with Top Countries Data, Market Share, Growth Analysis, Opportunities and Forecast To 2024 -…

Healthcare Nanotechnology Market 2020 Research Report provides Emerging Market trends, Market Segmentation, regional outlook and comprehensive analysis on different market segments. It also provides key analysis on the market status of the Healthcare Nanotechnology manufacturers with best facts and figures, meaning, definition, SWOT analysis, expert opinions and the latest developments across the globe.This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Final Report will add the analysis of the impact of COVID-19 on this industry.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT REQUEST SAMPLE

Short Description About Healthcare Nanotechnology Market :

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Get a Sample PDF of reporthttps://www.360researchreports.com/enquiry/request-sample/13841588

The research covers the current Healthcare Nanotechnology market size of the market and its growth rates based on 5-year records with company outline ofKey players/manufacturers:

Scope of the Healthcare Nanotechnology Market Report:

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

The global Healthcare Nanotechnology market is valued at 160800 million USD in 2018 and is expected to reach 255500 million USD by the end of 2024, growing at a CAGR of 9.7% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Healthcare Nanotechnology.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Healthcare Nanotechnology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Healthcare Nanotechnology market by product type and applications/end industries.

Get a Sample Copy of the Healthcare Nanotechnology Market Report 2020

Report further studies the market development status and future Healthcare Nanotechnology Market trend across the world. Also, it splits Healthcare Nanotechnology market Segmentation by Type and by Applications to fully and deeply research and reveal market profile and prospects.

Major Classifications are as follows:

Major Applications are as follows:

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Healthcare Nanotechnology in these regions, from 2014 to 2024, covering

This Healthcare Nanotechnology Market Research/Analysis Report Contains Answers to your following Questions

Inquire more and share questions if any before the purchase on this report at https://www.360researchreports.com/enquiry/pre-order-enquiry/13841588

Major Points from Table of Contents:

1. Market Overview1.1 Healthcare Nanotechnology Introduction1.2 Market Analysis by Type1.3 Market Analysis by Applications1.4 Market Dynamics1.4.1 Market Opportunities1.4.2 Market Risk1.4.3 Market Driving Force

2.Manufacturers Profiles

2.4.1 Business Overview2.4.2 Healthcare Nanotechnology Type and Applications2.4.2.1 Product A2.4.2.2 Product B

3.Global Healthcare Nanotechnology Sales, Revenue, Market Share and Competition By Manufacturer (2019-2020)

3.1 Global Healthcare Nanotechnology Sales and Market Share by Manufacturer (2019-2020)3.2 Global Healthcare Nanotechnology Revenue and Market Share by Manufacturer (2019-2020)3.3 Market Concentration Rates3.3.1 Top 3 Healthcare Nanotechnology Manufacturer Market Share in 20203.3.2 Top 6 Healthcare Nanotechnology Manufacturer Market Share in 20203.4 Market Competition Trend

4.Global Healthcare Nanotechnology Market Analysis by Regions

4.1 Global Healthcare Nanotechnology Sales, Revenue and Market Share by Regions4.1.1 Global Healthcare Nanotechnology Sales and Market Share by Regions (2014-2019)4.1.2 Global Healthcare Nanotechnology Revenue and Market Share by Regions (2014-2019)4.2 North America Healthcare Nanotechnology Sales and Growth Rate (2014-2019)4.3 Europe Healthcare Nanotechnology Sales and Growth Rate (2014-2019)4.4 Asia-Pacific Healthcare Nanotechnology Sales and Growth Rate (2014-2019)4.6 South America Healthcare Nanotechnology Sales and Growth Rate (2014-2019)4.6 Middle East and Africa Healthcare Nanotechnology Sales and Growth Rate (2014-2019)

5.Healthcare Nanotechnology Market Forecast (2020-2024)5.1 Global Healthcare Nanotechnology Sales, Revenue and Growth Rate (2020-2024)5.2 Healthcare Nanotechnology Market Forecast by Regions (2020-2024)5.3 Healthcare Nanotechnology Market Forecast by Type (2020-2024)5.3.1 Global Healthcare Nanotechnology Sales Forecast by Type (2020-2024)5.3.2 Global Healthcare Nanotechnology Market Share Forecast by Type (2020-2024)5.4 Healthcare Nanotechnology Market Forecast by Application (2020-2024)5.4.1 Global Healthcare Nanotechnology Sales Forecast by Application (2020-2024)5.4.2 Global Healthcare Nanotechnology Market Share Forecast by Application (2020-2024)

6.Sales Channel, Distributors, Traders and Dealers6.1 Sales Channel6.1.1 Direct Marketing6.1.2 Indirect Marketing6.1.3 Marketing Channel Future Trend6.2 Distributors, Traders and Dealers

7.Research Findings and Conclusion

8.Appendix8.1 Methodology8.2 Data Source

Continued..

Purchase this report (Price3480 USD for a single-user license) https://www.360researchreports.com/purchase/13841588

About Us:

360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:Name: Mr. Ajay MoreEmail: [emailprotected]Organization: 360 Research ReportsPhone: +44 20 3239 8187/ +14242530807

For More Related Reports Click Here :

Data Center Busway Market Share 2020 : Top Countries Data, Defination, Business Opportunity, SWOT Analysis, Applications, Trends and Forecast to 2026

Turbo Molecular Pumps Market Size 2020 Global Industry Brief Analysis by Top Countries Data, Market Share, Defination, Industry Trends, News and significant Growth With Regional Trends By Forecast 2026

Metal Casting Robots Market Size 2020 : Top Countries Data, Market Share, Growth Opportunities, Defination, Emerging Technologies, Trends,Growth, Segments, Landscape and Demand by Forecast to 2026

View original post here:
Healthcare Nanotechnology Market 2020 : Industry Outlook with Top Countries Data, Market Share, Growth Analysis, Opportunities and Forecast To 2024 -...

Global Healthcare Nanotechnology (Nanomedicine) Market 2020 |Size, Trends, Comprehensive Research Study, Development Status, Opportunities, Future…

There is a continuous growth in Healthcare Nanotechnology (Nanomedicine) Market in last five years and also continue for the forecast year 2023. Healthcare Nanotechnology (Nanomedicine) industry report analyses the outline of the global market with respect to major regions and segmented by types and applications. Healthcare Nanotechnology (Nanomedicine) Market covers top manufacturers, product scope, market overview, market opportunities, market risk, market driving force, technological advancement, distributors, traders, dealers, research findings.

Get a Sample Copy Of The Report At https://www.absolutereports.com/enquiry/request-sample/13102426

The global healthcare nanotechnology market is expected to witness a CAGR of 15.1%. North America currently dominates the market, and is expected to maintain its position over the forecasted period.

Rising Applications in Oncology

Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies. Nanoscale objects are used by themselves or as parts of larger devices containing multiple nanoscale objects. It has the potential to change the current methods of diagnosing and treating cancer. Translation of nano-based cancer therapies and diagnostics has witnessed significant progress and several more developments are in the pipeline. The increasing incidence of cancer and importance of nanomedicine in modern cancer treatment procedures, are expected to drive the demand for nanomedicines during the forecast period.The other factors includes increasing incidence of cardiovascular diseases, increasing research funding and rising awareness of nanomedicine application.

High Costs of Nanotechnology-Based Medical Devices

Cost is the main factor that is often overlooked, which is specifically important in the face of ever increasing healthcare cost and unpredictable reimbursement environment. There are several FDA approved nanoparticle-based products in the market, which can be compared with their non-nanoparticle based counterparts. Although these formulations may be more efficient and less toxic than their counterparts, their costs may also be significantly high. The average cost per dose of anticancer drug doxorubicin is about USD 62-162, compared to USD 5,594 for Doxil, which is a nanoparticle containing doxorubicin. Therefore, owing to the inability of the industry to find a cost-effective method of scaling up the production, the cost of nanomedicine therapies is likely to remain high over the forecast period. This high cost of nanoparticle-assisted medicine is hindering the growth of the market. The other restraining factor also include time-consuming product approval.

US Dominates the Market

Geographically, the United States currently dominates the market, and is expected to maintain its position over the forecast period. In addition to the booming R&D activities, the United States has also initiated several measures in the recent times, to advance and develop the nanotechnology applications in the healthcare sector. Owing to the large geriatric population, growing need for diagnostics and augmented cancer therapies, government initiatives, and rising awareness of nanomedicines, the US healthcare nanotechnology sector is expected to witness a substantial growth during the forecast period.

Major Players in the Market

The Major Players are ABBOTT LABORATORIES, COMBIMATRIX CORPORATION, GE HEALTHCARE, SIGMA-TAU PHARMACEUTICALS INC., JOHNSON & JOHNSON, MALLINCKRODT PLC, MERCK & COMPANY INC., NANOSPHERE INC., PFIZER, INC. AND CELGENE CORPORATION amongst others.

Major Regions: US,Canada,Mexico,France,UK,Germany,Italy,Spain,Rest of Europe,India,China,Japan,Australia,Japan,Rest of APAC,GCC,South Africa,Rest of Middle East and Africa,Brazil,Argentina,Rest of South America

Inquire Or Share Your Questions If Any Before The Purchasing This Report https://www.absolutereports.com/enquiry/pre-order-enquiry/13102426

Reasons to Purchase this Report:

Major Points Covered in Table of Content of Healthcare Nanotechnology (Nanomedicine) Market forecast 2023

1. Introduction of Healthcare Nanotechnology (Nanomedicine) Market Report

1.1 Study Deliverables

1.2 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Study Phases

2.4 Econometric Modelling

3. Executive Summary

4. Market Overview and Healthcare Nanotechnology (Nanomedicine) Market Trends

4.1 Introduction

4.2 Market Trends

4.3 Porters Five Force Framework

4.3.1 Bargaining Power of Suppliers

4.3.2 Bargaining Power of Consumers

4.3.3 Threat of New Entrants

4.3.4 Threat of Substitute Products and Services

4.3.5 Competitive Rivalry within the Industry

5. Healthcare Nanotechnology (Nanomedicine) Market Dynamics

5.1 Drivers

5.2 Restraints

5.3 Opportunities

6.Global Healthcare Nanotechnology (Nanomedicine) Market, Segmented by Size

7. Global Healthcare Nanotechnology (Nanomedicine) Market, Segmented by Technology Type

Purchase This Report (Price 4250 USD for single user license) https://www.absolutereports.com/purchase/13102426

8. Global Healthcare Nanotechnology (Nanomedicine) Market, Segmented by Geography

8.1 North America

8.1.1 United States

8.1.2 Canada

8.1.3 Mexico

8.1.4 Others

8.2 South America

8.2.1 Brazil

8.2.2 Argentina

8.2.3 Others

8.3 Asia-Pacific

8.3.1 China

8.3.2 Japan

8.3.3 India

8.3.4 Others

8.4 Europe

8.4.1 United Kingdom

8.4.2 Germany

8.4.3 France

8.4.4 Others

8.5 Africa and Middle East

8.5.1 UAE

8.5.2 South Africa

8.5.3 Saudi Arabia

8.5.4 Others

9. Competitive Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Developments of Key Players

10. Key Vendor Analysis (Overview, Products & Services, Strategies)

11. Future Outlook of the Market

12. Disclaimer

And Many More.

For Detail TOC Click Here

About Absolute Reports:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact Info:

Name: Ajay More

Email: [emailprotected]

Organization: Absolute Reports

Phone: +14242530807/+44203239 8187

Our Other report :Glass Bubbles Market 2020 Analysis Manufacturing Cost Structure, Industry Chain Structure, Raw Material and Suppliers Opportunities & Future Potential 2024

Automotive Part Cleaners & Degreasers Market 2020 Research Analysis by Product Overview and Scope and Suppression Systems Forecasts 2024

Flux Removers Market 2020 Structure, Research Methodology Forecast to 2024

2-Methyl-Propenoic Acid Market 2020 Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities & Future Potential 2024

Global Heavy Duty Casters Market 2020 Segmented by Application and Geography Trends, Growth and Forecasts to 2026

Product Type Coverage of Global Solid Bleached Board Market by Market Size & Forecast, Major Company of Product Type 2020-2026

Global Monobutylamine (MMA) Market 2020 Size, Share, Growth, Trends and Forecast 2026, Business Opportunities and Future Investments

Ready to Assemble Furnitures Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis & Forecast: 2026

Global Swept Frequency Capacitive Sensing Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026

Global Grape Seed Oil Market 2020 Size, Share, Growth, Trends and Forecast 2024, Business Opportunities and Future Investments

Global Reusable Container Market Share, Growth, Trend Analysis and Forecast from 2020-2026; Consumption Capacity by Volume and Production Value

Read the original post:
Global Healthcare Nanotechnology (Nanomedicine) Market 2020 |Size, Trends, Comprehensive Research Study, Development Status, Opportunities, Future...

Nanomedicine Market Competitive Research And Precise Outlook 2020 To 2026 – Cole of Duty

The global Nanomedicine market report is a comprehensive research that focuses on the overall consumption structure, Demand, Revenue and Forecast till 2026. The report focuses on key companies in the global Nanomedicine industry, market segments, competition, and the growth drivers, constraints and SWOT analysis. This report focuses on Nanomedicine volume and value at the global level, regional level and company level.

(Get up to 20% discount on this)

Request for sample:

https://www.marketinsightsreports.com/reports/07212156415/global-nanomedicine-market-size-status-and-forecast-2020-2026/inquiry?Mode=52

Nanomedicine Market will research at CAGR of 13.5% during the Forecast Period 2017 to 2025.

The Report includestop leading companies Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences

Global Nanomedicine Market, By Type

Quantum dots

Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Global Nanomedicine Market, By Application

oncology

Infectious diseases

Cardiology

Orthopedics

Others

Key Market Trends

Neurological Diseases is Expected to Show Better Growth in the Forecast Period

A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. The Parkinsons Foundation Prevalence Project estimates that 930,000 people in the United States will be living with Parkinson Disease (PD) by the year 2020. This number is predicted to rise to 1.2 million by 2030. Therefore recent years has observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies. The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimers disease, Parkinson disease, tumor, neuro-AIDS, among others,

North America is Expected to Hold the Largest Share of the Market

In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy.

For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs was developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role. In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Furthermore, most of the companies are investing in R&D. Nanotechnology is thus likely to play a significant role in the delivery of drugs, which is expected to further advance the research and development activities, over the forecast period.

Global Nanomedicine Market Segmentation by Region:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Russia, Rest of Europe, Central & South America

Table of Contents:

Report Overview:It includes Nanomedicine market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary:This section of the report gives information about Nanomedicine market trends and shares market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players:Here, key players of the Nanomedicine market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study:All of the regions and countries analyzed in the Nanomedicine market report is studied on the basis of the market size by application, the market size by product, key players, and market forecast.

Key Players:This part of the Nanomedicine market report discusses expansion plans of companies, key mergers and acquisitions, funding and investment analysis, company establishment dates, revenues of manufacturers, and their areas served and manufacturing bases.

Browse This Report:

https://www.marketinsightsreports.com/reports/07212156415/global-nanomedicine-market-size-status-and-forecast-2020-2026?Mode=52

Customization of the Report

The report could be customized according to the clients specific research requirements. No additional cost will be required to pay for limited additional research.

Marketinsightsreports are inspired to help our clients grow by providing business insight with our huge market intelligence repository.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234

Mob: +91-750-707-8687

[emailprotected]

[emailprotected]

All the reports that we list have been tracking the impact of COVID-19 the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team

Follow this link:
Nanomedicine Market Competitive Research And Precise Outlook 2020 To 2026 - Cole of Duty

Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy – DocWire News

This article was originally published here

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul 22:e1654. doi: 10.1002/wnan.1654. Online ahead of print.

ABSTRACT

Lung cancer is considered to cause the most cancer-related deaths worldwide. Due to the deficiency in early-stage diagnostics and local invasion or distant metastasis, the first line of treatment for most patients unsuitable for surgery is chemotherapy, targeted therapy or immunotherapy. Nanocarriers with the function of improving drug solubility, in vivo stability, drug distribution in the body, and sustained and targeted delivery, can effectively improve the effect of drug treatment and reduce toxic and side effects, and have been used in clinical treatment for lung cancer and many types of cancers. Here, we review nanoparticle (NP) formulation for lung cancer treatment including liposomes, polymers, and inorganic NPs via systemic and inhaled administration, and highlight the works of overcoming drug resistance and improving cancer immunotherapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.

PMID:32700465 | DOI:10.1002/wnan.1654

See more here:
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy - DocWire News

Value of Healthcare Nanotechnology (Nanomedicine) Market Predicted to Surpass US$ by the of 2075 2015 2021 Bulletin Line – Bulletin Line

Global Healthcare Nanotechnology (Nanomedicine) market Research presents a Comprehensive scenario Which can be segmented according to producers, product type, applications, and areas. This segmentation will provide deep-dive analysis of the Healthcare Nanotechnology (Nanomedicine) business for identifying the growth opportunities, development tendencies and factors limiting the development of the marketplace. This report features forecast market information based on previous and present Healthcare Nanotechnology (Nanomedicine) industry scenarios and growth facets. Each of the Essential regions coated in Healthcare Nanotechnology (Nanomedicine) report are North America, Europe, Asia-Pacific, South America, Middle East and Africa. The Healthcare Nanotechnology (Nanomedicine) market share and market prognosis of every region from 2020-2027 are presented within this report. A deep study of Healthcare Nanotechnology (Nanomedicine) marketplace dynamics will help the market aspirants in identifying the business opportunities that will lead to accumulation of earnings. This segment can efficiently determine the Healthcare Nanotechnology (Nanomedicine) hazard and key market driving forces.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/6370

The Healthcare Nanotechnology (Nanomedicine) report is segmented to provide a clear and Precise view of this international Healthcare Nanotechnology (Nanomedicine) market statistics and market quotes. Healthcare Nanotechnology (Nanomedicine) report Information represented in the form of graphs, charts, and statistics will show the Healthcare Nanotechnology (Nanomedicine) growth rate, volume, goal customer analysis. This report presents the significant data to all Healthcare Nanotechnology (Nanomedicine) business aspirants which will facilitate useful business decisions.

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are:

Key features of this report

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/6370

The Healthcare Nanotechnology (Nanomedicine) report cover following data points:

Part 1: This part enlists the global Healthcare Nanotechnology (Nanomedicine) marketplace Overview, covering the simple market debut, market analysis by kind, applications, and areas. Healthcare Nanotechnology (Nanomedicine) industry states and prognosis (2020-2027) is presented in this part. Additionally, Healthcare Nanotechnology (Nanomedicine) market dynamics saying the chances, market risk, and key driving forces are studied.

Part 2: This part covers Healthcare Nanotechnology (Nanomedicine) manufacturers profile based On their small business overview, product type, and application. Additionally, the sales volume, Healthcare Nanotechnology (Nanomedicine) product price, gross margin analysis, and Healthcare Nanotechnology (Nanomedicine) market share of every player is profiled in this report.

Part 3 and Part 4: This part presents the Healthcare Nanotechnology (Nanomedicine) competition Based on earnings, earnings, and market share of each producer. Part 4 covers the Healthcare Nanotechnology (Nanomedicine) market scenario based on regions. Region-wise Healthcare Nanotechnology (Nanomedicine) sales and growth (2015-2019) is studied in this report.

America and Europes Healthcare Nanotechnology (Nanomedicine) industry by countries. Under this Healthcare Nanotechnology (Nanomedicine) revenue, market share of those nations like USA, Canada, and Mexico is provided. Under Europe Healthcare Nanotechnology (Nanomedicine) report contains, the countries such as Germany, UK, France, Russia, Italy, Russia and their sales and growth is coated.

Part 7, Part 8 and Part 9: These 3 sections covers Healthcare Nanotechnology (Nanomedicine) The earnings and expansion in these regions are presented in this Healthcare Nanotechnology (Nanomedicine) industry report.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/6370

Part 10 and Part 11: This component depicts the Healthcare Nanotechnology (Nanomedicine) marketplace Share, earnings, sales by product type and application. The Healthcare Nanotechnology (Nanomedicine) sales growth seen during 2012-2020 is covered in this report.

Related to Healthcare Nanotechnology (Nanomedicine) market (2020-2027) for every region. The sales channels including indirect and direct Healthcare Nanotechnology (Nanomedicine) advertising, traders, distributors, and future trends are presented in this report.

Part 14 and Part 15: These components present Healthcare Nanotechnology (Nanomedicine) market key Research findings and judgment, research methodology, and data sources are covered.

Therefore, Global Healthcare Nanotechnology (Nanomedicine) report is a complete blend covering all The very important market aspects.

View post:
Value of Healthcare Nanotechnology (Nanomedicine) Market Predicted to Surpass US$ by the of 2075 2015 2021 Bulletin Line - Bulletin Line

Nanomedicines Market Research On Present State & Future Growth Prospects to 2027 | Sirnaomics, BlueWillow Biologics, Cristal Therapeutics – Cole…

Nanomedicines Market research added by the insight partners, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.

The application of nanotechnology in the medical field is called nanomedicine. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. These can pass directly through the cellular membranes and interact with the cellular DNA and proteins, giving better desired results as compared to the traditional form of medicines. These nanomedicines are normally used across applications such as, diagnosis, targeted drug delivery and imaging.

Download PDF sample of the report @ https://www.theinsightpartners.com/sample/TIPRE00004589/

Major Players Included in this report are as follows

Nanomedicines Market: Regional analysis includes:

The global nanomedicines market is segmented on the basis of product, application and type. Based on product, the market is classified as therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. On the basis of application, the market is classified as clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other applications. On the basis of type, the market is categorized as nanoparticles, nanoshells, nanotubes and nanodevices.

This report on Nanomedicines Market delivers an in-depth analysis that also comprises an elaborate assessment of this business. Also, segments of the Nanomedicines Market have been evidently elucidated in this study, in addition to a basic overview pertaining to the markets current status as well as size, with respect to the profit and volume parameters. The study is ubiquitous of the major insights related to the regional spectrum of this vertical as well as the companies that have effectively gained a commendable status in the Nanomedicines Market.

The Nanomedicines Market research covers an exhaustive analysis of the following data:

Historical and future growth of the global Nanomedicines Market.

Segmentation of the Nanomedicines Market to highlight the growth prospects and trends impacting these segments.

Changing consumption behavior of customers across various regions.

Regional analysis on the basis of market share, growth outlook, and key countries.

Agreements, product launches, acquisitions, and R&D projects of different Nanomedicines Market players.

The Nanomedicines Market research addresses critical questions, such as

Why is region surpassing region in terms of value by the end of 2027?

How are the consumers using Nanomedicines for various purposes?

Which players are entering into collaborations in the market of the Nanomedicines?

At what rate has the global Nanomedicines Market been growing throughout the historic period?

In terms of value, which segment holds the largest share?

Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPRE00004589/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email: [emailprotected]

Continue reading here:
Nanomedicines Market Research On Present State & Future Growth Prospects to 2027 | Sirnaomics, BlueWillow Biologics, Cristal Therapeutics - Cole...

Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -…

Healthcare Nanotechnology (Nanomedicine) Marketreport provides in-depth COVID19 impact analysis ofMarket Overview, Product Scope, Market Drivers, Trends, Opportunities,Market Driving Force and Market Risks. It also profile the topmost prime manufacturers (Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International) are analyzed emphatically by competitive landscape contrast, with respect toPrice, Sales,Capacity, Import, Export, Consumption, Gross, Gross Margin, Revenue and Market Share. Healthcare Nanotechnology (Nanomedicine) industry breakdown data are shown at the regional level, to show the sales, revenue and growth by regions.Healthcare Nanotechnology (Nanomedicine) Market describe Healthcare Nanotechnology (Nanomedicine) Sales Channel,Distributors, Customers, Research Findings and Conclusion, Appendix and Data Source.

Key Target Audience of Healthcare Nanotechnology (Nanomedicine) Market:Manufacturers of Healthcare Nanotechnology (Nanomedicine), Raw material suppliers, Market research and consulting firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Healthcare Nanotechnology (Nanomedicine) market.

Get Free Sample PDF (including full TOC, Tables and Figures)of Healthcare Nanotechnology (Nanomedicine)[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2041239

In-Depth Qualitative Analyses Include Identification and Investigation Of The Following Aspects:Healthcare Nanotechnology (Nanomedicine) Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porters Fiver Forces.

Summary of Healthcare Nanotechnology (Nanomedicine) Market:It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Healthcare Nanotechnology (Nanomedicine) market foreach application, including-

Anticancer CNS Product Anti-infective Other

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type, primarily split into-

Nanomedicine Nano Medical Devices Nano Diagnosis Other

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2041239

Important Healthcare Nanotechnology (Nanomedicine) Market Data Available In This Report:

Contact:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://bit.ly/2Sepby2

Go here to see the original:
Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -...

Nanomedicine Market with Emerging Trends, Global Scope and Demand 2020 to 2026 – The Canton Independent Sentinel

The Global Nanomedicine Market Report contains essential details of the industry, intended to help the customers identify the optimum approaches to get ahead in the market and make well-informed decisions. An extensive overview of the global sector included in the report examines vital market information to forecast the growth of the market in the forecast duration. The CAGR of the market for the coming years to 2026 has been estimated based on a detailed assessment of the market with authentic and relevant information pertaining to the different segments of the sector. The driving and restraining factors prevailing in the industry have been studied to predict their impact on the growth of the Nanomedicine market in the coming years.

This is the only report that is inclusive of the current effect of the coronavirus on the market and its future trends. The coronavirus has widely impacted the world economy, and its aftereffects are elucidated in detail in the report for the Nanomedicine market.

The sample of the report can be availed by [emailprotected] https://www.reportsanddata.com/sample-enquiry-form/1048

It provides an elaborate breakdown of critical market statistics, market estimation, and profiles of leading players operating in the global Nanomedicine industry.

In market segmentation by manufacturers, the report covers the following companies-

Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., AMAG Pharmaceuticals, Bio-Gate AG, Celgene and Johnson & Johnson

Nanomedicine product types, applications, geographies, and end-user industries are the key market segments that are comprised in this study. The report speculates the prospective growth of the different market segments by studying the current market standing, performance, demand, production, sales, and growth prospects existing in the market.

Get a discount on your copy of the [emailprotected] https://www.reportsanddata.com/discount-enquiry-form/1048

Major highlights of the global Nanomedicine market report:

The report depicts all the analytical details in a well-structured manner, for example, in the statistics, graphs, tables, through which users can more easily grasp detailing. Moreover, it discusses accurate forecasts and gives a detailed research methodology.

The global Nanomedicine market report answers some important questions for you:

Read the full Research Report along with a table of contents, facts and figures, charts, graphs, [emailprotected] https://www.reportsanddata.com/report-detail/nanomedicine-market

To summarize, the global Nanomedicine market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

David is an Experience Business writer who regularly contribute to the blog, He specializes in manufacturing news

Read the original here:
Nanomedicine Market with Emerging Trends, Global Scope and Demand 2020 to 2026 - The Canton Independent Sentinel

Nanobiotix 2019 Q4 and Annual Revenues – Business Wire

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext : NANO ISIN : FR0011341205 the Company), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited annual revenues for Q4 and the unaudited revenues for the year ended December 31, 2019.

2019 Revenues

In K

Twelve months Ended

December 31st, 2019

Twelve months Ended

December 31st, 2018

Revenues

68

105

Of which licenses

-

-

Of which services

68

99

Other sales

-

6

Revenue for Q4 2019

In K

Q4 2019

Q3 2019

Q2 2019

Q1 2019

Revenues

20

11

32

5

Of which licenses

-

-

-

-

Of which services

20

11

32

5

Activity and results

Nanobiotixs revenue for the fourth quarter amounted to approximatively 20k.

Most of the revenues generated by the Company during this period result from the recharge of costs related to our license and collaboration agreement with PharmaEngine.

Overall, Nanobiotixs annual revenue in 2019 amounted to approximatively 68k.

The amount of cash and cash equivalent as of December 31st, 2019 amounted to 35 094k. This amount does not include the research tax credit related to 2018, normally expected in Q4 which was received in February 2020.

In November 2019, Nanobiotix announced promising results from a pre-clinical immuno-oncology study of NBTXR3 at the 2019 Annual Meeting of the Society for Immunotherapy of Cancer (SITC). In the study, conducted at The University of Texas MD Anderson Cancer Center, researchers studied NBTXR3 activated by radiation therapy in combination with anti-PD-1 treatment in immunocompetent mice. Combination treatment that included NBTXR3 and anti-PD-1 increased local control of the irradiated tumor, generated a marked abscopal effect, decreased the number of spontaneous lung metastases, and significantly increased survival when compared to other treatments in the study, including anti-PD-1 combined with radiation therapy alone. The results indicated that the combination treatment has the potential to achieve an equivalent abscopal effect at a lower dose of radiation.

The study also included an in vivo RadScopal model in which a second tumor received a low dose of radiation while the first tumor received a full dose. In this model, researchers evaluated NBTXR3 activated by radiation therapy combined with anti-PD-1 and anti-CTLA-4 treatment. In the study, combination treatment triggered better local control, along with significant increases in abscopal effect and survival, when compared to all other tested combinations. Several complete responses were observed in the second tumor of the group that received the NBTXR3 combination, while none were observed in the other groups. Nanobiotix believes these results could pave the way for the use of NBTXR3 to improve treatment outcomes for immunooncology patients, including checkpoint inhibitor non-responders.

On December 16th 2019, Nanobiotix received the French 2019 Prix Galien award for Most Innovative MedTech. This award recognizes outstanding biomedical and medical technology product achievements that improve the human condition.

2020 Financial agenda

Nanobiotix plans to announce its financial and operating results as follows:

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany. The Company also possesses an affiliate, Curadigm, located in Paris, France and Cambridge, MA in the U.S.

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix registered with the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.19-018 on April 30, 2019 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

See the original post here:
Nanobiotix 2019 Q4 and Annual Revenues - Business Wire

Ohio State researchers testing breathalyzer to detect COVID-19 – The Ohio State University News

One of the most common COVID-19 tests involves a long swab pressed deep into the nasal cavities and while the test can be administered quickly, it has been described as unpleasant and uncomfortable.

Now researchers at The Ohio State University are working on a testing system that would require a simple exhaled breath. Perena Gouma is the primary investigator of a team developing a breathalyzer device that will sample breath for key biomarkers of the infection. She says it would serve as an alternative to current tests that are expensive, can take a long time to get results and require specialized personnel to do the sampling and to analyze the results.

Gouma, director of the Advanced Ceramics Research Laboratory and professor in the College of Engineering, is working with co-investigator Andrew Bowman, associate professor of veterinary preventive medicine. The project was awarded a nearly $200,000 National Science Foundation EAGER grant this month under a program supporting exploratory, early-stage research on untested, but potentially transformative, ideas or approaches.

Breath analysis is not really a technique that is used widely in the medical field yet, so it is considered early-stage work, Gouma said. [We] have a sensor device that detects nitric oxide and VOCs (volatile organic compounds) in breath and can be used to tell you about the onset of an infectious disease.

In addition to nitric oxide, the device examines two other metabolites that could specifically indicate the presence of a COVID-19 infection even in asymptomatic patients. Exhaling once in the breathalyzer may help with earlier detection of the onset of the disease, as well as with monitoring of the severity of the infection, which could help reduce the risk for worsening of the symptoms and allow timely therapeutic intervention, she said.

The new project builds upon Goumas invention of a hand-held breathmonitor that may provide early detection of flu before symptoms appearprior to her arrival at Ohio State. The COVID-19 breathalyzer involves advances on nanomaterials for detecting specific breath gases at the concentrations of interest for making a diagnosis.

The breathalyzer gives results rapidly (15 seconds response time), it is extremely inexpensive, and it is easy to use so that there is no need for trained personnel to perform the test, Gouma said. The results can be viewed directly on the display or they can be transferred to the physician wirelessly.

We are working on making these hand-held monitors that will be widely distributed and theyre very inexpensive, she said. The technology evolved from the sensors used for monitoring gases in an automotive exhaust thats how we started on breath analysis 20 years ago.

Gouma said the NSF-funded project would not have been possible without the collaboration with the College of Veterinary Medicine, the College of Medicine and the Wexner Medical Center. She said these connections make Ohio State very appealing for interdisciplinary research between engineering and medicine (nanomedicine).

Thats one of the advantages of Ohio State. You dont find many institutions that have the No. 1 vet med school in the world and also a world-class medical school, she said. Its also serendipity because COVID-19 is a zoonosis, a disease that comes from animals, and the vet med school had years of experience studying coronaviruses and the flu in animals.

Furthermore, the Wexner Medical Center has been treating COVID-19 patients from the beginning of the pandemic, so it offers unique insights to this project.

Gouma said the collaboration is critical for engineers developing medical diagnostics for humans and animals who need to consult with colleagues who have expertise in medicine to ensure that the ideas have merit and to validate their claims through clinical trials.

If the device proves to be accurate, portable and effective, it could be used to screen travelers before they step on a flight or to test students and teachers before they head back into the classroom. It would also be used in the Medical Intensive Care Units and in every hospital and doctors office as a bedside test. Gouma said the breathalyzer technology may become the platform to help detect metabolic problems like cancer, Alzheimers disease or diabetes, by choosing the appropriate biomarker

Excerpt from:
Ohio State researchers testing breathalyzer to detect COVID-19 - The Ohio State University News

New Comprehensive Report on Nanorobotics Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like – 3rd Watch News

Nanorobotics Market Overview 2020 2025

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The risingtechnology in Nanorobotics Marketis also depicted in thisresearchreport. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/21633

Key Competitors of the Global Nanorobotics Market are: , Bruker, JEOL, Thermo Fisher Scientific, Ginkgo Bioworks, Oxford Instruments, EV Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik,

Historical data available in the report elaborates on the development of the Nanorobotics on national, regional and international levels. Nanorobotics Market Research Report presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis.

Major Product Types covered are: , Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based,

Major Applications of Nanorobotics covered are: , Nanomedicine, Biomedical, Mechanical,

This study report on global Nanorobotics market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities.

To get this report at a profitable rate.: https://reportsinsights.com/discount/21633

The fundamental purpose of Nanorobotics Market report is to provide a correct and strategic analysis of the Nanorobotics industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.

Market Scenario:

The report further highlights the development trends in the global Nanorobotics market. Factors that are driving the market growth and fueling its segments are also analyzed in the report. The report also highlights on its applications, types, deployments, components, developments of this market.

Highlights following key factors:

:-Business descriptionA detailed description of the companys operations and business divisions.:-Corporate strategyAnalysts summarization of the companys business strategy.:-SWOT AnalysisA detailed analysis of the companys strengths, weakness, opportunities and threats.:-Company historyProgression of key events associated with the company.:-Major products and servicesA list of major products, services and brands of the company.:-Key competitorsA list of key competitors to the company.:-Important locations and subsidiariesA list and contact details of key locations and subsidiaries of the company.:-Detailed financial ratios for the past five yearsThe latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Nanorobotics-Market-21633

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Read the original here:
New Comprehensive Report on Nanorobotics Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like - 3rd Watch News

Parvus Therapeutics, Novartis Partner on Novel Diabetes Nanomedicine – Drug Discovery & Development

Parvus Therapeutics, a biopharmaceutical company developing disease-modifying nanomedicines to halt or reverse autoimmune disease without causing general immune suppression, has entered into a license and collaboration agreement with Novartis for its lead Navacim for treating type 1 diabetes. Navacims constitute a novel pharmacological class of therapeutic comprised of nanoparticles (NPs) coated with disease-relevant peptide-major histocompatibility complexes (pMHCs) that alter the behavior of disease-causing T lymphocytes. Navacims are the first biopharmaceuticals to demonstrate in preclinical models the ability to restore immune tolerance in a disease-specific manner throughin vivoformation and expansion of regulatory T-cells (T-regs) without causing general immune suppression.

Under the terms of the agreement, Novartis receives exclusive, worldwide rights to use Parvus Navacim technology to develop and commercialize products for the treatment of type 1 diabetes (T1D) and will be responsible for clinical-stage development and commercialization activities. Parvus will be primarily responsible for conducting the ongoing preclinical work for the T1D program and filing the IND in collaboration with Novartis through a joint steering committee. Parvus has received an upfront payment and will receive research funding to support preclinical activities. In addition, Parvus is eligible to receive downstream development, regulatory, and sales milestone payments, as well as product royalties. Novartis has also made an equity investment in Parvus.

T1D Navacims are composed of an iron oxide nanoparticle conjugated with multiple copies of a peptide derived from a pancreatic autoantigen, presented in the context of an MHC molecule. Preclinical studies have shown that Navacims achieve their therapeutic effect by reprogramming cognate pathogenic T cells into tissue-specific beneficial T-regs and thereafter inducing their systemic expansion. The expanded T-regs target and suppress the autoimmune disease-causing immune cells, sparing other immune cells and restoring the immune system to the normal steady state. Navacims have the potential, therefore, to specifically treat the autoimmune disease without increasing the risk of infection.

This is a transformative collaboration for Parvus. We are excited by this strong endorsement of the science behind our Navacim platform, as well as the opportunity to collaborate closely with a globally recognized leader in the field of immunology and autoimmune disease, stated Janice M. LeCocq, CEO of Parvus. "This will augment our resources across the Navacim platform and accelerate the development of our T1D program. We are also pursuing the development of multiple Navacims that target autoimmune diseases where there is high unmet need for disease-modifying drugs without causing systemic immunosuppression.

See the article here:
Parvus Therapeutics, Novartis Partner on Novel Diabetes Nanomedicine - Drug Discovery & Development

Immix adds Biotech VC Mesa Verde to Investor Syndicate and Receives IRB Approval to Enroll Patients in Phase 1b/2a Cancer Study in the United States -…

LOS ANGELES, Dec. 17, 2019 /PRNewswire/ -- Immix Biopharma, Inc., announced today the first closing of a convertible note financing to support the clinical testing of its lead compound Imx-110 in advanced solid tumors. Mesa Verde managing director, Carey Ng, PhD, MBA, also joined the Board.

Immix CEO, Ilya Rachman, MD, PhD, MBA, shared, "We are thrilled to bring on Mesa Verde and Carey as we continue to build our team with executives and board members with successful experience in guiding early-stage clinical companies through similar phases of rapid growth."

With this additional funding, Immix will begin enrolling patients at US-based sites in its study testing Imx-110 in a Phase 1b/2a trial in advanced solid tumors. Immix received IRB approval to begin dosing patients at Synergy Hematology Oncology with offices in Los Angeles and Encino, CA. Dr. Levon Qasabian, MD will be the principal investigator, who stated that, "We are excited to explore the potential of this promising drug and offer it to patients with advanced tumors and limited treatment options."

Interim readouts from the Phase 1b/2a trial in Australia are 100% clinical benefit rate (akin to disease control rate) for all patients who completed the 5th cohort and at least 2 cycles as scheduled - with the longest duration of response being 8-months of stable disease. No treatment-related serious adverse events have been observed to-date and dose escalation is continuing. For information about participating in this study, please visit clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03382340

Immix is also opening a call for investigator initiated studies where the company will provide its lead compound Imx-110 at no charge.

About Imx-110Imx-110 is a first-in-class combination therapy designed to inhibit cancer resistance and evolvability while inducing apoptosis. Imx-110 contains NF-kB/Stat3/pan-kinase inhibitor curcumin combined with a small amount of doxorubicin encased in a nano-sized delivery system for optimal tumor penetration. The nanoparticle is tunable in that it can be bound to various targeting moieties, allowing it to deliver even more payload to tumors or other cell populations of interest, if needed. Imx-110 showed preclinical efficacy in glioblastoma, multiple myeloma, triple-negative breast, colorectal, ovarian, and pancreatic tumor models with the mechanism of action being a 5x increase in cancer cell apoptosis compared to doxorubicin alone, and a wholesale shift in the tumor microenvironment post administration.

About the CompanyImmix Biopharma, Inc. is a privately-held, biopharmaceutical firm focused on developing safe and effective therapies for cancer patients. The company was founded by Vladimir Torchilin, Ph.D., D.Sc., Director of the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University; physician-scientist and clinical researcher Ilya Rachman, MD, PhD, MBA; and Sean D. Senn, JD, MSc., MBA, a senior biotechnology patent attorney. Immix's founding investor is a family office focused on harnessing scientific advances in order to engineer transformative and effective cancer treatments. For more information visit http://www.immixbio.com.

Media ContactRyan Witt+1 (888) 958-1084info@immixbio.com

View original content:http://www.prnewswire.com/news-releases/immix-adds-biotech-vc-mesa-verde-to-investor-syndicate-and-receives-irb-approval-to-enroll-patients-in-phase-1b2a-cancer-study-in-the-united-states-300975006.html

SOURCE Immix Biopharma, Inc.

Continue reading here:
Immix adds Biotech VC Mesa Verde to Investor Syndicate and Receives IRB Approval to Enroll Patients in Phase 1b/2a Cancer Study in the United States -...

Nanomedicine Award 2017: applications are now open! – Cordis News

The European Technology Platform for Nanomedicine (ETPN) and the EU-funded project ENATRANS, announce the launching of the 3rd edition of the Nanomedicine Award, which aim to promote and reward two excellent innovative nanomedicine-based solutions that could bring significant benefits to patients, answering thereby unmet medical needs. The winners in 2 categories will be announced and rewarded during the BIO-Europe conference in Berlin in November 2017. Apply Now!

Open to companies as well as to academic and private researchers across the globe, candidates should: - present totally new approaches based on Nanomedicine for the diagnosis and/or therapy of human diseases - describe explicit and defined potential market.

Applications will be assessed by a panel of highly-qualified nanomedicine, pharma, medtech and investment specialists.

The Award ceremony will take place during BIO-Europe 2017 in Berlin (Germany), on 7 November 2017.

Both winners will benefit from a full registration to BIO-Europe 2017 including the participation in the partnering event and a public presentation of the awarded projects. In addition, they will be granted an individual session with the experts of the Translation Advisory Board (TAB, http://www.nanomedtab.eu), a presentation slot during the ETPN Annual Event 2018 as well as a 1-year free membership to the ETPN (www.etpnanomedicine.eu).

The Award is supported by the EBD Group, the leading partnering firm for the global life science industry, and Nanobiotix, a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer.

THE DEADLINE TO SUBMIT CANDIDATURES IS 15 AUGUST 2017. APPLY ONLINE AT http://nanomedicine-award.com/apply-now/

Read more:
Nanomedicine Award 2017: applications are now open! - Cordis News

Iran to hold intl. nanotech. conf. in May – Mehr News Agency – Mehr News Agency – English Version

The INN Secretariat, based in Iran, is offering a two-day conference and workshop onNanotechnology and Nanomedicine, known as NTNM2017,scheduled to be held fromMay 2 to 3, 2017at Materials Energy Research Center (MERC), Alborz.

This is a scientific congregation, which brings together researchers, scientists, key decision makers, and industry professionals on the common platform for a brief yet intense period of discussion, collaboration, and addressing nanomedicine-related subjects.

The conference/workshop will be held on the following themes: Surface Modification Strategies; Nanomedicine, Diagnosis, and Therapy; Pharmaceutics and Drug Delivery Systems; Toxicology and Risk; Assessment of Nanomaterials; Tissue Engineering and Regenerative Medicine; Nanotechnology and Environmental Health; and Nanobiodevices and Biosensors.

NTNM2017 aims at strengthening the relations and technological collaborations inter/intra Islamic member states and improving transfer of experience among the academic researchers. It also seeks to promote joint cooperation between scientific, research, and technology centers of OIC member states with research and technology centers outside the OIC member states.

Over 20 professors and prominent researchers from 57 Muslim and non-Muslim countries will take part in the conference.

MS/3964205

Read more:
Iran to hold intl. nanotech. conf. in May - Mehr News Agency - Mehr News Agency - English Version

Yuehe Lin named to National Academy of Inventors – WSU News

Yuehe Lin

Yuehe Lin, professor in the School of Mechanical and Materials Engineering, has been named a fellow of the National Academy of Inventors (NAI).

He was cited for his highly prolific spirit of innovation in creating or facilitating inventions that have made a tangible impact on the quality of life, economic development, and welfare of society, according to the selection committee. Lin is one of 168 NAI Fellows for 2019, which is the highest professional distinction accorded solely to academic inventors. The program includes more than 1,000 fellows from 250 universities around the world that hold more than 41,500 U.S. patents.

Dr Lin has made significant research contributions with real-world impact in the fields of energy and health, said Mary Rezac, dean of WSUs Voiland College of Engineering and Architecture. His hugely varied work from finding possible new ways to treat cancer to innovations in water splitting for a future hydrogen economy and development of a better catalyst for fuel cells often comes down to simple solutions that can provide real change and improvements in peoples lives.

With WSU since 2013, Lin, who also holds a joint appointment at Pacific Northwest National Laboratory, conducts research in nanotechnology, particularly development of small-scale devices, materials and analytical systems for biomedical diagnosis, drug delivery and energy and environmental applications.

He has more than 500 peer-reviewed publications, which have been cited more than 50,500 times, according to Google Scholar. He has an h-index, a measure of a scientists productivity and impact, of 112. He has been named among the worlds most highly cited researchers every year from 2014 to 2019 by the Web of Science Group.

He has received funding from the National Institutes of Health, U.S. Centers for Disease Control and Prevention and U.S. Departments of Energy and Defense. He holds more than 20 patents, some of which have been licensed to industrial partners for commercialization.

Lin is a fellow of the American Association for the Advancement of Science, Royal Society of Chemistry and American Institute of Medical and Biological Engineering as well as a member of the Washington State Academy of Sciences. He serves as editor or editorial board member for approximately 20 international journals, including Advance Materials Technologies; Analytica Chimica Acta; Biosensors and Bioelectronics; Electroanalysis; International Journal of Nanomedicine; Research; Journal of Nanoscience and Nanotechnology; and Sensors and Actuators B.

Lin will join the induction ceremony for fellows on April 10 as part of the annual Conference of the National Academy of Inventors in Phoenix, AZ.

Go here to read the rest:
Yuehe Lin named to National Academy of Inventors - WSU News